Dr Reddys Laboratories (RDY) Enterprise Value (2012 - 2026)

Dr Reddys Laboratories' Enterprise Value history runs 15 years deep, the most recent figure standing at -$174.0 million for Q1 2026.

• In Q1 2026, Enterprise Value fell 3.85% year-over-year to -$174.0 million; the TTM figure through Mar 2026 stood at -$174.0 million (down 3.85% YoY), while the FY2026 annual figure was -$940.4 million, down 450.86% from the prior year.
• Enterprise Value was -$174.0 million for Q1 2026 at Dr Reddys Laboratories, down from -$2.3 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of $403.3 million in Q3 2022 to a low of -$751.8 million in Q1 2023.
• Historically, Enterprise Value has averaged -$119.8 million across 5 years, with a median of -$99.0 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Enterprise Value soared 287.03% in 2022, then slumped 237.31% in 2023.
• A 5-year view of Enterprise Value shows it stood at $403.3 million in 2022, then plunged by 119.53% to -$78.8 million in 2023, then surged by 111.54% to $9.1 million in 2024, then plunged by 124.97% to -$2.3 million in 2025, then sank by 7571.17% to -$174.0 million in 2026.
• The last three Enterprise Value figures came in at -$174.0 million (Q1 2026), -$2.3 million (Q4 2025), and -$158.6 million (Q3 2025), per Business Quant data.